Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity |
| |
Authors: | Yamanouchi Jun Rainbow Dan Serra Pau Howlett Sarah Hunter Kara Garner Valerie E S Gonzalez-Munoz Andrea Clark Jan Veijola Riitta Cubbon Rose Chen Show-Ling Rosa Raymond Cumiskey Anne Marie Serreze David V Gregory Simon Rogers Jane Lyons Paul A Healy Barry Smink Luc J Todd John A Peterson Laurence B Wicker Linda S Santamaria Pere |
| |
Affiliation: | Julia McFarlane Diabetes Research Centre (JMDRC) and Department of Microbiology and Infectious Diseases, Institute of Inflammation, Infection and Immunity, Faculty of Medicine, The University of Calgary, Calgary, Alberta T2N 4N1, Canada. |
| |
Abstract: | ![]() Autoimmune diseases are thought to result from imbalances in normal immune physiology and regulation. Here, we show that autoimmune disease susceptibility and resistance alleles on mouse chromosome 3 (Idd3) correlate with differential expression of the key immunoregulatory cytokine interleukin-2 (IL-2). In order to test directly that an approximately twofold reduction in IL-2 underpins the Idd3-linked destabilization of immune homeostasis, we show that engineered haplodeficiency of Il2 gene expression not only reduces T cell IL-2 production by twofold but also mimics the autoimmune dysregulatory effects of the naturally occurring susceptibility alleles of Il2. Reduced IL-2 production achieved by either genetic mechanism correlates with reduced function of CD4(+) CD25(+) regulatory T cells, which are critical for maintaining immune homeostasis. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|